International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US

This article, published in the Ocotber 2010 issue of PharmacoEconomics, examines health technology assessments (HTA) in Canada, Sweden, Scotland, The Netherlands and Australia and identifies seven shared characteristics that potentially serve as insights for development of CER in the United States. 


Among the study’s key conclusions:

  • CER should be responsive to stakeholder needs by minimizing the time to make assessments, maximizing transparency, and using a process that is fair and is conducted with universally agreed-upon standards.
  • Unlike other countries in which the HTA process assesses benefits to inform a single payer, the diverse multi-payer system in the U.S. suggests that national efforts here are best focused on generating comparative effectiveness evidence.
  • Using CER to identify therapeutic benefit among specific demographic groups (e.g., the elderly or racial and ethnic minorities) and individuals with specific genetic characteristics, disabilities, or multiple conditions may be difficult to achieve because few randomized trials can really detect differences, and thus such studies are rare.

Due to copyright issues, the article must be downloaded from the PharmacoEconomics website.

Newsletter Volume

E.V.I.dently July 2015

NPC MessageWho Can Say What, and When? Could We See Changes in Biopharmaceutical Communications?It’s possible that 2015 could be the year that we see...
Blog Post

CER Tweets of the Week: PCORI Blog on Pipeline to Proposal Initiative, AJMC and V-BID Center Twitter Chat (July 20-24)

This week, comparative effectiveness research (CER) stakeholders shared a blog by the Patient-Centered Outcomes Research Institute (@PCORI) about its...
Blog Post

Are You a Clinical Decision-Maker? Register for Expert-Endorsed CER Collaborative Tools to Be “Better at What You Do”

The growing availability of new research poses challenges and opportunities for those creating, communicating or using research to inform clinical...
Blog Post

CER Tweets of the Week: PIPC Opinion Poll Shows Support for CER, PCORI Annual Meeting (July 13-17)

This week, the Partnership to Improve Patient Care (@PIPCpatients) released a national opinion poll confirming broad public support for comparative...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

State Medicaid Directors Share Views on Comparative Effectiveness Research And Its Impact on Policy in National Pharmaceutical Council Survey

(Washington, DC, April 16, 2015)—A new survey conducted on behalf of the National Pharmaceutical Council (NPC) shows that state Medicaid directors...
Press Release

NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making

(Washington, DC, March 26, 2015)—A new survey of health care stakeholders reveals continued optimism that comparative effectiveness research (CER)...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Commentary and Testimony Page

Chain Drug Review – Commentary: “Health Care Outlook for 2015”

This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
YouTube Videos

Comparative Effectiveness Research and the Environment for Health Care Decision-Making

During a March 26, 2015 webinar, the National Pharmaceutical Council discussed the results of its annual stakeholder survey on comparative...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
Blog Post

CER Tweets of the Week: PCORI Blog on Pipeline to Proposal Initiative, AJMC and V-BID Center Twitter Chat (July 20-24)

This week, comparative effectiveness research (CER) stakeholders shared a blog by the Patient-Centered Outcomes Research Institute (@PCORI) about its...
Blog Post

Are You a Clinical Decision-Maker? Register for Expert-Endorsed CER Collaborative Tools to Be “Better at What You Do”

The growing availability of new research poses challenges and opportunities for those creating, communicating or using research to inform clinical...
Blog Post

CER Tweets of the Week: PIPC Opinion Poll Shows Support for CER, PCORI Annual Meeting (July 13-17)

This week, the Partnership to Improve Patient Care (@PIPCpatients) released a national opinion poll confirming broad public support for comparative...
Blog Post

CER Tweets of the Week: PCORI Opens Funding Cycle for PCOR Methods Improvement, JCER Welcomes New Ed Board Member (June 29 – July 2)

This week, comparative effectiveness research (CER) stakeholders shared the news that the Patient-Centered Outcomes Research Institute (@PCORI) has...
  •  
  • 1 of 14
  • >